Sebi green lights issues of Sagility, Senores Pharma

MUMBAI: Sagility India and Senores Pharmaceuticals have received approvals from the Securities and Exchange Board of India (Sebi) for their proposed initial public offerings (IPOs). The regulator issued its final observations on the draft papers last week.

When a company receives a final observation from Sebi, it’s a signal from the regulator to go ahead with the IPO process. Sagility India’s IPO consists solely of an offer for sale (OFS) of 984.4 million shares by promoter Sagility BV. The company provides technology-driven services to insurance settlement entities and healthcare providers.

Senores’ IPO comprises a fresh issue of Rs 500 crore and an OFS of 2.7 million shares by promoters and other investors.